Effect of TXA on Reducing Bruising After Filler Injection

Recruiting now · Phase 2 · Has a placebo group

Conditions studied: Facial Filler Injections, Hyaluronic Acid, Tranexamic Acid

In brief

The goal of this clinical trial is to look at the effect tranexamic acid (TXA) may have on reducing bruising, swelling, and pain after facial filler injection. The main question it aims to answer is: * Does the addition of TXA to hyaluronic acid (HA) reduce bruising, swelling, and tenderness after HA injection? Participants will receive the study medication along with the standard facial filler injection and complete surveys.

Key facts

Study ID
NCT06665594
Run by
University of Wisconsin, Madison
People needed
40
Starts
2025-12-05
Expected to finish
2026-11-01
Last updated by the study team
2026-07-23

Who can join

Age: 18 and older, up to 89. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.